Researchers from Sechenov First Moscow State Medical University Detail Findings in Anemia (Anemia and Quality of Life of Chronic Kidney Disease Patients On Renal Replacement Therapy By Programmed Hemodialysis).

Předmět:
Zdroj: Hematology Week; 4/13/2023, p469-469, 1p
Abstrakt: According to the news reporters, the research concluded: "HRQOL assessment is important tool for selecting, monitoring and correction of anemia therapy among patients with chronic kidney disease on hemodialysis." Keywords: Moscow; Russia; Anemia; Dialysis; Health and Medicine; Hematologic Diseases and Conditions; Hemic and Lymphatic Diseases and Conditions; Hemodialysis; Kidney; Nephrology; Quality of Life; Renal Replacement Therapy EN Moscow Russia Anemia Dialysis Health and Medicine Hematologic Diseases and Conditions Hemic and Lymphatic Diseases and Conditions Hemodialysis Kidney Nephrology Quality of Life Renal Replacement Therapy 469 469 1 04/10/23 20230413 NES 230413 2023 APR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Data detailed on Hematologic Diseases and Conditions - Anemia have been presented. [Extracted from the article]
Databáze: Complementary Index